Alan raises €480 million Series G led by Prosus, boosting European health‑tech fundingExecutive summary: Alan secured a €480 million Series G funding round led by Prosus. The deal signals strong investor confidence in European health‑tech and adds to record venture funding in the sector. Alan (health‑tech unicorn), Prosus (lead investor), and existing backers (not named). Proceeds will fund product development, geographic expansion, and potential follow‑on M&A or IPO activity.Alan, a European health‑tech unicorn, closed a Series G round totaling €480 million, with Prosus acting as lead investor. The round values the company at a multi‑billion‑euro level, though the exact valuation was not disclosed. The investment reflects continued appetite for digital health ventures despite broader market volatility. Prosus’s involvement may bring strategic synergies with its existing consumer‑internet portfolio.Open the full case file on Beyond →
Social Pulse
AI estimate · not scraped